Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
NCT Number: NCT00230438
Delivery of conformal radiation therapy following radical prostatectomy is limited by the inability to define the clinical target volume (CTV). This stems from a poor understanding of patterns of local recurrence and limitations of standard imaging techniques.Magnetic Resonance Imaging (MRI) is a promising modality for imaging the prostatic bed following radical prostatectomy. MRI provides more detailed postoperative anatomy to guide CTV delineation, the ability to document local recurrence patterns, and a method to assess intrafraction prostatic bed motion and deformity to define appropriate planning target volume margins. The aim of this pilot study is to develop a technique for external beam radiation therapy (EBRT) following radical prostatectomy based on MRI-delineation of the CTV. Twenty patients will be enrolled in this pilot, development phase.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Phase 2
Toronto, Ontario, M5G 2M9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
pT2 + positive surgical margins ) pT3 ) PSA ≤ 2ng/ml Persistently elevated PSA at 3 months )
Exclusion criteria
Time frame: After data acquisition
Time frame: After data acquisition
Time frame: After data acquisition
Time frame: After data acquisition
Time frame: After data acquisition
Time frame: After data acquisition
Time frame: After data acquisition
University Health Network, Toronto
Other
A Pilot Study to Develop a Technique for External Beam Radiotherapy After Radical Prostatectomy Based on MRI-Delineation of the Clinical Target Volume
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04108208
Genital Diseases, Genital Diseases, Male
Beijing, China
View Trial DetailsNCT03834493
Genital Diseases, Genital Diseases, Male
Mobile, Alabama, United States
View Trial DetailsNCT02854982
Genital Diseases, Genital Diseases, Male
Nîmes, Gard, France
View Trial DetailsNCT03421015
Disease Attributes, Genital Diseases
Lille, France
View Trial Details